Wilmington Savings Fund Society FSB Buys New Stake in Henry Schein, Inc. (NASDAQ:HSIC)

Wilmington Savings Fund Society FSB bought a new position in Henry Schein, Inc. (NASDAQ:HSIC) during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 1,496 shares of the company’s stock, valued at approximately $109,000.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Cromwell Holdings LLC lifted its holdings in shares of Henry Schein by 93.4% during the third quarter. Cromwell Holdings LLC now owns 352 shares of the company’s stock worth $26,000 after buying an additional 170 shares during the last quarter. Summit Securities Group LLC bought a new stake in Henry Schein in the 2nd quarter valued at $31,000. Blue Trust Inc. boosted its holdings in Henry Schein by 104.2% in the 2nd quarter. Blue Trust Inc. now owns 931 shares of the company’s stock valued at $60,000 after purchasing an additional 475 shares during the period. Farther Finance Advisors LLC grew its position in Henry Schein by 58.9% in the 3rd quarter. Farther Finance Advisors LLC now owns 933 shares of the company’s stock worth $68,000 after purchasing an additional 346 shares during the last quarter. Finally, Livforsakringsbolaget Skandia Omsesidigt increased its holdings in shares of Henry Schein by 282.1% during the 3rd quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,490 shares of the company’s stock worth $109,000 after purchasing an additional 1,100 shares during the period. Institutional investors and hedge funds own 96.62% of the company’s stock.

Insider Transactions at Henry Schein

In other news, COO Michael S. Ettinger sold 12,240 shares of the company’s stock in a transaction that occurred on Monday, November 18th. The shares were sold at an average price of $75.00, for a total transaction of $918,000.00. Following the transaction, the chief operating officer now directly owns 87,706 shares in the company, valued at approximately $6,577,950. This represents a 12.25 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 1.14% of the company’s stock.

Henry Schein Trading Down 2.4 %

Shares of HSIC stock opened at $68.95 on Friday. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46. The company has a market capitalization of $8.60 billion, a P/E ratio of 28.37, a P/E/G ratio of 2.31 and a beta of 0.87. Henry Schein, Inc. has a 12-month low of $63.67 and a 12-month high of $82.63. The firm has a 50-day moving average price of $72.43 and a 200 day moving average price of $70.13.

Henry Schein (NASDAQ:HSIC) last announced its earnings results on Tuesday, November 5th. The company reported $1.22 EPS for the quarter, topping the consensus estimate of $1.17 by $0.05. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The business had revenue of $3.17 billion for the quarter, compared to the consensus estimate of $3.24 billion. During the same period in the previous year, the business earned $1.32 EPS. Henry Schein’s revenue was up .4% compared to the same quarter last year. Research analysts forecast that Henry Schein, Inc. will post 4.78 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of equities research analysts recently weighed in on HSIC shares. Mizuho initiated coverage on Henry Schein in a research note on Wednesday, December 4th. They set a “neutral” rating and a $75.00 price target on the stock. Evercore ISI boosted their price objective on Henry Schein from $70.00 to $74.00 and gave the company an “in-line” rating in a research report on Tuesday, October 8th. StockNews.com upgraded Henry Schein from a “sell” rating to a “hold” rating in a research note on Thursday, November 7th. Finally, Barrington Research reiterated an “outperform” rating and set a $82.00 price target on shares of Henry Schein in a research note on Wednesday, November 6th. Seven analysts have rated the stock with a hold rating, four have issued a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, Henry Schein currently has a consensus rating of “Moderate Buy” and a consensus price target of $78.89.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.